Did Exponent’s (EXPO) Insider Promotions Reshape Its Leadership Blueprint and Investment Narrative?
Exponent, Inc. has announced significant leadership changes, including the appointments of Eric Anderson as CFO and John Pye as President, effective May 1, 2026. These promotions of long-tenured insiders are expected to reinforce the company's culture and focus on innovation. The article discusses how these changes could influence Exponent's ability to capitalize on complex technological work and address concerns about utilization and margin pressures.
Exponent Promotes Pye and Anderson to Top Roles
Exponent, Inc., an engineering and scientific consulting firm, has promoted John Pye to President and Eric Anderson to Chief Financial Officer. Both executives will report to CEO Catherine Corrigan, with Pye overseeing daily operations and Anderson managing financial strategy. These appointments are expected to guide the firm's growth and strategic direction.
Exponent Elevates Leadership Team with New President and CFO
Exponent, Inc., a leading engineering and scientific consulting firm, announced significant leadership changes, promoting John Pye to President and Eric Anderson to Chief Financial Officer. These appointments, effective May 1, 2026, are part of the company's focus on innovation and long-term growth. Additionally, Richard Schlenker is nominated to the Board of Directors, and Karen Richardson will become the new Board Chairman.
Exponent announces leadership reshuffle and board transition plans
Exponent (EXPO) has announced a leadership reshuffle and board transition plans. John Pye will become President and Eric Anderson will be CFO, effective May 1, 2026, while Chairman Paul Johnston will retire on June 4, 2026, with Karen Richardson taking over as chair. These changes signal Exponent's commitment to internal succession and continuity, as well as preserving institutional knowledge on the board.
Exponent appoints John D. Pye as President and Eric Anderson as CFO; Paul R. Johnston to retire
Exponent has announced key leadership changes, appointing John D. Pye as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026. Additionally, director Paul R. Johnston is set to retire on June 4, 2026. The company provided background details for the new appointees and outlined some board and committee role changes.
Exponent names new president and CFO, board chairman
Exponent, Inc. (NASDAQ:EXPO) has announced significant leadership changes effective May 1, 2026, including John Pye becoming President and Eric Anderson taking on the role of Chief Financial Officer. Additionally, Karen Richardson will succeed Paul Johnston as Chairman of the Board. These changes occur as the company maintains a strong financial position and has consistently raised its dividend for 13 years, despite its stock trading near its 52-week low.
What Is Exponent, Inc.'s (NASDAQ:EXPO) Share Price Doing?
This article examines Exponent, Inc.'s share price performance, highlighting its recent trading activity and year-to-date change. It notes that the stock has risen by 12% over the last week and provides an overview of the company's valuation metrics.
EXPO Earning Date, Earning Analysis and Earning Prediction
This article provides an earnings analysis and prediction for EXPO, noting its latest report on February 5, 2026, which showed strong revenue and EPS surprises. It discusses analyst forecasts for Q1 2026, projecting $144.47M in revenue and $0.55 EPS, alongside historical stock price reactions to earnings announcements. The piece concludes with insight from EXPO's Q4 2025 earnings call, highlighting a positive outlook driven by strong operational performance and strategic growth areas like AI.
SG Americas Securities Boosts Exponent Stock Holdings
SG Americas Securities LLC significantly increased its holdings in Exponent, Inc. (NASDAQ:EXPO) during the fourth quarter of 2025, purchasing an additional 29,600 shares, bringing its total to 36,610 shares valued at $2.5 million. This 422.3% increase in stake highlights growing institutional interest in Exponent's diversified consulting services. The investment underscores the firm's potential for continued growth and profitability in the scientific and engineering consulting sector.
SG Americas Securities LLC Increases Stock Holdings in Exponent, Inc. $EXPO
SG Americas Securities LLC significantly increased its stake in Exponent, Inc. by 422.3% in the fourth quarter, now owning 36,610 shares valued at $2.54 million. This move comes as Exponent reported strong Q4 earnings, beating estimates with EPS of $0.49 and revenue of $147.4 million, and raised its quarterly dividend. Despite insider selling, institutional investors collectively hold 92.37% of the company's stock, and analysts maintain a "Moderate Buy" rating with an average price target of $90.00.
Exponent Inc Stock: Engineering Consulting Leader with Strong North American Exposure and Growth Pot
Exponent Inc (EXPO) is presented as a premier engineering and scientific consulting firm, specializing in failure analysis and litigation support. The article highlights its recession-resistant business model, strong North American presence, and consistent revenue growth driven by complex, high-value projects. Investors are encouraged to consider EXPO for its stable financial health, niche market position, and potential for growth in an increasingly technical and litigious global economy.
Exponent Inc Stock: Engineering Consulting Leader with Strong North American Exposure and Growth Pot
Exponent Inc is a leading engineering and scientific consulting firm specializing in failure analysis and litigation support, particularly valued by North American investors for its recession-resistant model. The company's diverse expertise, high-value non-recurring projects, and strong financial health with a debt-free balance sheet contribute to its stable, high-margin business. Exponent operates with a focus on niche technical expertise, serving various sectors from transportation to health sciences, and offers a strong value proposition as a quality compounder with defensive qualities in volatile markets.
Exponent, Inc. Experiences Revision in Its Stock Evaluation Amid Market Challenges
Exponent, Inc., a small-cap construction firm, has seen its stock performance decline significantly over the past year, underperforming the S&P 500. Technical indicators predominantly suggest a bearish sentiment, reinforced by MACD, Bollinger Bands, KST, and Dow Theory metrics. The company's stock price currently stands at 64.47, reflecting a 21.42% drop over the year and a 32.56% decline over three years, despite a 52-week high of 83.92.
Exponent, Inc. Hits New 52-Week Low at USD 63.25 Amid Declining Performance
Exponent, Inc., a small-cap construction firm, has reached a new 52-week low of USD 63.25, marking a significant 30.96% decline in stock value over the past year. Despite a strong return on equity of 21.03% and a low debt-to-equity ratio, the company faces challenges with only 7.79% net sales growth and 7.55% operating profit growth over the last five years. This performance significantly lags behind the S&P 500, indicating ongoing market volatility for Exponent.
Exponent Inc (EXPO) Stock Price Quote Today & Current Price Chart
This article provides current stock price quotes and trading conditions for Exponent Inc (EXPO) on Capital.com, focusing on CFD trading. It details financial market specifications like spread, overnight funding adjustments, margin requirements, and key stats including previous close, open, and year-to-date change. The page also features links to recent articles on other major stocks like Amazon, Siemens, Microsoft, and HENSOLDT, showcasing Capital.com's broader market analysis.
Tudor Investment Corp ET AL Has $1.31 Million Stake in Exponent, Inc. $EXPO
Tudor Investment Corp ET AL significantly reduced its stake in Exponent, Inc. by 67.6% in the third quarter, now holding shares valued at $1.31 million. Despite this reduction, institutional investors collectively own 92.37% of the company, with other firms like Voleon Capital Management and Voloridge Investment Management increasing their positions. Exponent recently beat earnings expectations, reported a strong return on equity, raised its quarterly dividend, and holds a "Moderate Buy" consensus rating from analysts.
How Exponent Inc. (EXPO) Affects Rotational Strategy Timing
Stock Traders Daily's AI models indicate that Exponent Inc. (EXPO) is showing weak near and mid-term sentiment, with a neutral long-term outlook. Despite this, an exceptional 29.9:1 risk-reward setup targets an 8.5% gain against a 0.3% risk. The analysis provides three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, along with multi-timeframe signal analysis for support and resistance levels.
EXPO SEC Filings - Exponent Inc 10-K, 10-Q, 8-K Forms
This page provides access to Exponent Inc.'s SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, along with insider trading forms. It highlights Exponent's financial condition, operating performance across its engineering and environmental segments, and material events such as quarterly results and dividend declarations. The platform also offers AI-powered summaries to help investors understand these complex regulatory documents.
EXPO SEC Filings - Exponent Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access Exponent Inc.'s (EXPO) official regulatory filings, including annual 10-K, quarterly 10-Q, material event 8-K forms, and insider trading reports. It details how investors can use these documents to understand the company's financial condition, operating performance, and key events, offering AI-powered summaries for complex information. The article also highlights recent insider transactions, ownership stakes, and dividend announcements for Exponent Inc.
Exponent (NASDAQ:EXPO) Hits New 1-Year Low After Analyst Downgrade
Exponent Inc. (NASDAQ:EXPO) shares recently reached a new 52-week low after JPMorgan Chase & Co. lowered its price target on the stock. Despite insider selling activity, the company reported strong quarterly earnings, beating analyst expectations for both EPS and revenue, and increased its quarterly dividend. Analysts currently rate Exponent as a "Moderate Buy" with an average target price of $90.00.
J.P. Morgan Keeps Their Buy Rating on Exponent (EXPO)
J.P. Morgan analyst Tomohiko Sano maintained a Buy rating on Exponent (EXPO) with a $95.00 price target, despite negative insider sentiment characterized by increased insider selling. Exponent recently reported a quarterly revenue of $147.43 million and a net profit of $24.76 million, showing growth compared to the previous year. Another firm, TipRanks xAI, also issued a Buy rating while TipRanks Anthropic downgraded the stock to Hold.
EXPO Should I Buy
An analysis for Exponent Inc (EXPO) suggests that it is not a strong buy for long-term beginner investors due to bearish technical indicators, increased insider selling, and a lack of positive news catalysts, despite consistent financial growth and positive long-term analyst outlooks. The company's Q4 2025 financial performance showed revenue and net income growth, and analysts from JPMorgan and UBS have price targets between $85 and $95. However, the stock has de-rated over the past year, and immediate action is not recommended.
Vanguard disaggregates holdings; subsidiaries to report EXPO positions (EXPO)
The Vanguard Group has filed an amendment to its Schedule 13G/A, reporting 0 shares of Exponent Inc. common stock. This change stems from an internal realignment on January 12, 2026, where certain Vanguard subsidiaries will now report their beneficial ownership separately, citing SEC Release No. 34-39538. The filing indicates a reporting structure change rather than a divestment, with future individual subsidiary filings expected to show their beneficial holdings.
Exponent, Inc. Forms Death Cross, Signaling Potential Bearish Trend Ahead
Exponent, Inc., a small-cap construction firm, has formed a Death Cross, indicating a potential bearish trend due to its short-term moving average crossing below its long-term moving average. The company has significantly underperformed the S&P 500 over the past year, with a decline of 18.56% compared to the S&P 500's 13.68% gain. Technical indicators like MACD show bearish trends, while RSI shows mixed signals, suggesting challenges ahead for Exponent, Inc.
JPMorgan Chase Reduces Stake in Exponent, Inc.
JPMorgan Chase & Co. has reduced its holdings in Exponent, Inc. by 24.7% during the third quarter of 2026, selling 157,457 shares and now owning 480,624 shares valued at $33,394,000. This move by the multinational investment bank, a significant investor in Exponent, could suggest a shift in investor sentiment or a portfolio adjustment regarding the engineering and scientific consulting firm.
Exponent, Inc. Experiences Revision in Stock Evaluation Amid Market Challenges
Exponent, Inc., a small-cap construction firm, has seen a significant decline in its stock performance over the past year, underperforming the S&P 500. The company's stock is currently trading within a volatile 52-week range, and technical indicators largely suggest a bearish sentiment. This performance highlights the need for strategic adjustments to address ongoing market challenges.
Zacks Industry Perspective Features Stantec, FTI Consulting, and Exponent
Zacks Equity Research highlights Stantec Inc. (STN), FTI Consulting (FCN), and Exponent (EXPO) as top picks in the Consulting Services industry due to robust economic conditions and strong demand for expert guidance. The sector, currently holding a Zacks Industry Rank of #70, shows significant growth potential driven by digital innovation and strategic planning. Despite lagging the S&P 500 in recent market performance, these companies exhibit strong financial health and promising outlooks, with rising EPS estimates and favorable Zacks Ranks.
Assessing Exponent (EXPO) Valuation After Recent Share Pullback And Mixed Growth Expectations
Exponent (EXPO) has seen its shares drop by 10% in three months and 18% over the past year, prompting a reevaluation of its valuation. While one analysis suggests it is 22% undervalued with a fair value of $85.50 due to expansion into high-growth areas like AI safety and distributed energy, another view highlights valuation risk given its high P/E ratio of 31x compared to the industry average of 18.9x. Investors are encouraged to assess these mixed signals, considering both growth opportunities and potential market sentiment shifts.
Exponent (EXPO) CEO receives 17,814 restricted stock units as equity award
Exponent Inc.'s President and CEO, Catherine Corrigan, was granted 17,814 restricted stock units on March 13, 2026, as a form of equity compensation. These units are directly owned and are exchangeable for Exponent common stock on a one-for-one basis, with a conversion and expiration date of March 13, 2030. This transaction, detailed in an SEC Form 4 filing, is an award acquisition and not a stock purchase or sale.
EXPO Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of Exponent Inc (EXPO), detailing its revenue breakdown, profitability margins, and a comparison with competitors. EXPO generates most of its revenue from engineering and scientific services, boasts high gross and operating margins, and maintains a strong Return on Equity. The comparison highlights EXPO's strong performance relative to peers like TPC and IHS in terms of gross margin.
Exponent Inc (EXPO) grants VP John Pye 5,938 restricted stock units
Exponent Inc.'s VP Global Offices & Innovation, John Pye, was granted 5,938 restricted stock units (RSUs) on March 13, 2026. These RSUs are a compensation award, convertible 1-for-1 into common stock, and are set to expire on March 13, 2030, indicating a long-term equity incentive. Pye now directly holds 5,938 RSUs following this transaction.
Exponent (EXPO) VP Joseph Sala awarded 9,798 restricted stock units
Exponent Inc.'s Group Vice President, Joseph Sala, was granted 9,798 Restricted Stock Units (RSUs) on March 13, 2026, as part of his equity compensation. These RSUs are convertible into Exponent common stock on a 1-for-1 basis, and Sala now holds 9,798 RSUs directly. The grant was made at no cash cost per unit, indicating routine executive compensation rather than a market transaction.
Exponent (NASDAQ: EXPO) VP awarded 10,688 restricted stock units
Exponent Inc.'s Group Vice President, Joseph Rakow, was granted 10,688 restricted stock units (RSUs) on March 13, 2026. These RSUs, valued at $0.00 each as they are an equity award, represent a right to receive an equal number of Exponent common shares. The grant results in Rakow holding 10,688 RSUs directly, with an exercise and expiration date of March 13, 2030.
Executive at Exponent (EXPO) receives 2,970 restricted stock units
Exponent Inc.'s Group Vice President, Richard Reiss, was granted 2,970 restricted stock units (RSUs) on March 13, 2026, as reported in a Form 4 SEC filing. These RSUs represent the right to receive an equal number of common stock shares and are considered routine equity-based compensation. The grant date is March 13, 2026, with an expiration date of March 13, 2030.
Zacks Industry Outlook Highlights Stantec, FTI Consulting and Exponent
Zacks Equity Research highlights Stantec Inc. (STN), FTI Consulting, Inc. (FCN), and Exponent, Inc. (EXPO) as key stocks to consider in the prospering Consulting Services industry. The industry is experiencing exponential growth, driven by economic recovery, strong demand, and digital transformation, leading to a "Buy" rating for these three companies. The article details how each company is uniquely positioned to capitalize on these market trends, through diversified offerings, technological innovation, and addressing significant global needs.
Exponent (NASDAQ: EXPO) grants CFO 10,688 restricted stock units
Exponent Inc.'s EVP & Chief Financial Officer, Richard L. Schlenker Jr., was granted 10,688 restricted stock units (RSUs) on March 13, 2026. This award, reported in a Form 4 SEC filing, represents a right to receive one share of common stock for each RSU. Following this compensation, Schlenker Jr. directly holds 10,688 restricted stock units, aligning his interests with shareholder outcomes.
Exponent (EXPO) grants 9,500 restricted stock units to group VP
Exponent Inc. (EXPO) reported that Group Vice President Maureen T. F. Reitman received a grant of 9,500 restricted stock units (RSUs) on March 13, 2026, as part of her equity compensation. These RSUs convert into common shares based on company terms and are set to expire in March 2030, with each RSU representing one share of Exponent common stock. This grant did not involve any cash purchase by the executive and is reflected in the SEC Form 4 filing.
Catherine Corrigan to sell 3,912 shares (NASDAQ: EXPO) under Form 144
Catherine Corrigan has filed a Form 144 indicating a proposed sale of 3,912 shares of Exponent Inc. (NASDAQ: EXPO) common stock. This sale stems from the exercise of stock options on March 16, 2026, with Morgan Stanley Smith Barney LLC handling the transaction. The filing also details previous sales by Corrigan under 10b5-1 plans, including 3,920 shares sold on February 17, 2026, and 1,663 shares sold on January 15, 2026.
Exponent (NASDAQ: EXPO) CHRO receives grant of 3,564 restricted stock units
Exponent Inc.'s Chief Human Resources Officer, Brian Kundert, was granted 3,564 restricted stock units (RSUs) on March 13, 2026, as reported in a recent SEC Form 4 filing. This transaction represents equity-based compensation, not an open-market purchase or sale, and each RSU corresponds to one share of common stock. Following this award, Kundert directly holds 3,564 restricted stock units.
Zacks Industry Perspective Features Stantec, FTI Consulting, and Exponent
Zacks Equity Research has highlighted Stantec Inc. (STN), FTI Consulting (FCN), and Exponent (EXPO) as key players in the Consulting Services industry, noting strong growth trends despite the sector lagging the S&P 500 in market performance. The industry benefits from robust economic conditions and demand for expert guidance in areas like digital transformation. FTI Consulting and Exponent are rated Zacks Rank #2 (Buy), while Stantec also holds a Zacks Rank #2, showcasing positive EPS revisions and potential for investors.
Exponent (EXPO) VP converts 5,510 RSUs, 1,756 shares withheld for taxes
Exponent Inc.'s Group Vice President, Maureen T. F. Reitman, converted 5,510 vested Restricted Stock Units (RSUs) into common stock on March 11, 2026. To cover tax withholding obligations, 1,756 shares were withheld by the company at a price of $70.03 per share. Following these transactions, Reitman directly owns 39,226 shares of Exponent Common Stock, categorizing this as a routine compensation and tax event rather than an open-market sale.
Exponent (EXPO) VP John Pye converts RSUs; shares withheld for taxes
Exponent Inc. VP John Pye converted 5,934 vested restricted stock units (RSUs) into common shares on March 11, 2026. To cover tax withholding obligations, 2,384 shares were withheld by the company at $70.03 per share, a tax-related disposition rather than an open-market sale. After these transactions, Pye directly holds 29,131 shares of Exponent common stock.
Exponent (EXPO) CEO Corrigan exercises RSUs and has shares withheld for taxes
Exponent Inc.'s President & CEO, Catherine Corrigan, exercised 12,716 vested Restricted Stock Units (RSUs) on March 11, 2026, converting them into common stock. To cover tax withholding obligations associated with this transaction, 6,156 shares were withheld by the company. After these actions, Corrigan directly holds 100,969 shares of Exponent common stock, with the filing indicating a compensation-related event rather than an open-market sale or purchase.
Exponent (NASDAQ: EXPO) VP converts 3,180 RSUs; 1,114 shares withheld for taxes
Exponent Group Vice President Joseph Sala converted 3,180 Restricted Stock Units into common shares on March 11, 2026. A total of 1,114 shares were withheld by the company at $70.03 each to cover tax obligations, leaving Sala with 2,066 directly held shares. This transaction is considered a routine equity compensation event and not an open-market trade.
First Trust Advisors LP Grows Stake in Exponent, Inc. $EXPO
First Trust Advisors LP significantly increased its stake in Exponent, Inc. (NASDAQ:EXPO) by 135.8% in the 3rd quarter, now owning 580,134 shares valued at over $40 million. Other institutional investors also adjusted their holdings, with hedge funds and institutional investors collectively owning 92.37% of the company's stock. Analysts have a "Moderate Buy" consensus rating for Exponent with a target price of $92.50, and recent insider selling activity has also been noted.
Geneva Capital Management LLC Sells 19,080 Shares of Exponent, Inc. $EXPO
Geneva Capital Management LLC reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 1% in the third quarter, holding 1,858,685 shares valued at $129.1 million, which constitutes about 2.2% of its portfolio. Despite this reduction, institutional ownership in Exponent remains high at 92.37%, with several major funds increasing their positions and Norges Bank initiating a significant stake. The company recently reported strong quarterly earnings, beating expectations with $0.49 EPS and $147.4 million in revenue, and has increased its quarterly dividend to $0.31 per share.
Neuberger Berman Group LLC Sells 43,247 Shares of Exponent, Inc. $EXPO
Neuberger Berman Group LLC reduced its stake in Exponent, Inc. by 2.7% in Q3, selling 43,247 shares and retaining 1,563,190 shares valued at about $108.61 million. The article notes Exponent's strong Q3 earnings, beating analyst expectations, and an increase in its quarterly dividend. Insider selling has also been reported, with the CEO and a VP selling shares, though insiders still collectively own 1.6% of the company.
The Zacks Analyst Blog Highlights Liquidity Services, Remitly Global, Exponent and Sezzle
This Zacks Analyst Blog highlights four stocks—Liquidity Services, Remitly Global, Exponent, and Sezzle—from the services sector that are poised for growth. The selection is based on the strong rebound in the U.S. services sector, indicated by the ISM Services PMI climbing to 56.1 in February. All featured companies hold either a Zacks Rank #1 (Strong Buy) or #2 (Buy), signaling favorable investment prospects.
GW&K Investment Management LLC Lowers Position in Exponent, Inc. $EXPO
GW&K Investment Management LLC reduced its stake in Exponent, Inc. (NASDAQ:EXPO) by 22.3% in Q3, selling 93,858 shares. This comes as Exponent reported strong quarterly earnings, beating expectations with $0.49 EPS and $147.43M in revenue, and increased its quarterly dividend to $0.31. Despite recent insider selling, analysts maintain a "Moderate Buy" rating with an average price target of $92.50.
The Zacks Analyst Blog Highlights Liquidity Services, Remitly Global, Exponent and Sezzle
This Zacks Analyst Blog highlights four companies—Liquidity Services, Remitly Global, Exponent, and Sezzle—as strong investment opportunities within the services sector. The recommendations come amidst a solid rebound in the U.S. non-manufacturing sector, indicated by a rise in the ISM Services PMI and increased business activity. These companies are noted for their positive earnings growth expectations and strong Zacks Rank.
